Current progress of 1,2,3-triazole hybrids as EGFR inhibitors for cancer therapy – a literature reviewHussam Elddin Nabeih Khasawneh, Ahmed Al‐Emam, Hamada Hashem et al.|RSC Advances|2025Cited by 14